![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 7, 2006
Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109
Corresponding Author: kunliang{at}umich.edu
Tuberous Sclerosis complex (TSC) is an autosomal dominant disease characterized by hamartoma formation in various organs. The two genes responsible for the disease, TSC1 and TSC2, have been identified. The TSC1 and TSC2 proteins, also called hamartin and tuberin, respectively, have been shown to regulate cell growth through inhibition of the mTOR pathway. TSC1 is known to stabilize TSC2 by forming a complex with TSC2, which is a GAP for the Rheb small GTPase. We have identified HERC1 as a TSC2 interacting protein. HERC1 is a 532kDa protein with an E3 ubiquitin ligase HECT domain. We observed that the interaction of TSC1 with TSC2 appears to exclude TSC2 from interacting with HERC1. Disease mutations in TSC2, which result in its destabilization, allow binding to HERC1 in the presence of TSC1. Our study reveals a molecular mechanism of how TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase from the TSC2 complex. Furthermore, these data reveal a possible biochemical basis of how certain disease mutations inactivate TSC2.
J. Biol. Chem, 10.1074/jbc.C500451200
Submitted on November 21, 2005
Revised on February 3, 2006
Accepted on February 7, 2006
TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. S. Pymar, F. M. Platt, J. M. Askham, E. E. Morrison, and M. A. Knowles Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms Hum. Mol. Genet., July 1, 2008; 17(13): 2006 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, C. C. Dibble, M. Matsuzaki, and B. D. Manning The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 Mol. Cell. Biol., June 15, 2008; 28(12): 4104 - 4115. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, H. Kenerson, L. Aicher, R. Miyaoka, J. Eary, J. Bissler, and R. S. Yeung The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake Am. J. Pathol., June 1, 2008; 172(6): 1748 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Meikle, K. Pollizzi, A. Egnor, I. Kramvis, H. Lane, M. Sahin, and D. J. Kwiatkowski Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function J. Neurosci., May 21, 2008; 28(21): 5422 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hu, S. Zacharek, Y. J. He, H. Lee, S. Shumway, R. J. Duronio, and Y. Xiong WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase Genes & Dev., April 1, 2008; 22(7): 866 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zheng, H. Ding, Z. Lu, Y. Li, Y. Pan, T. Ning, and Y. Ke E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells, March 1, 2008; 13(3): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Krymskaya Smooth Muscle like Cells in Pulmonary Lymphangioleiomyomatosis Proceedings of the ATS, January 1, 2008; 5(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bilanges, R. Argonza-Barrett, M. Kolesnichenko, C. Skinner, M. Nair, M. Chen, and D. Stokoe Tuberous Sclerosis Complex Proteins 1 and 2 Control Serum-Dependent Translation in a TOP-Dependent and -Independent Manner Mol. Cell. Biol., August 15, 2007; 27(16): 5746 - 5764. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival J. Neurosci., May 23, 2007; 27(21): 5546 - 5558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |